| REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer P Seibold, A Webb, ME Aguado-Barrera, D Azria, C Bourgier, M Brengues, ... Radiotherapy and Oncology 138, 59-67, 2019 | 68 | 2019 |
| Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients E Orlandi, NA Iacovelli, T Rancati, A Cicchetti, P Bossi, E Pignoli, ... Oral oncology 86, 266-272, 2018 | 33 | 2018 |
| A deep learning approach validates genetic risk factors for late toxicity after prostate cancer radiotherapy in a REQUITE multi-national cohort MC Massi, F Gasperoni, F Ieva, AM Paganoni, P Zunino, A Manzoni, ... Frontiers in oncology 10, 541281, 2020 | 22 | 2020 |
| Patterns in ano-rectal dose maps and the risk of late toxicity after prostate IMRT E Onjukka, C Fiorino, A Cicchetti, F Palorini, I Improta, G Gagliardi, ... Acta Oncologica 58 (12), 1757-1764, 2019 | 22 | 2019 |
| Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: Results from a large pooled population A Cicchetti, T Rancati, M Ebert, C Fiorino, F Palorini, A Kennedy, ... Physica Medica 32 (12), 1690-1697, 2016 | 21 | 2016 |
| A mesoscale computational model for microvascular oxygen transfer L Possenti, A Cicchetti, R Rosati, D Cerroni, ML Costantino, T Rancati, ... Annals of Biomedical Engineering 49, 3356-3373, 2021 | 20 | 2021 |
| Personalized dosimetry in targeted radiation therapy: a look to methods, tools and critical aspects R Danieli, A Milano, S Gallo, I Veronese, A Lascialfari, L Indovina, F Botta, ... Journal of Personalized Medicine 12 (2), 205, 2022 | 19 | 2022 |
| Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy A Alessi, A Lorenzoni, A Cavallo, B Padovano, NA Iacovelli, P Bossi, ... La radiologia medica 124, 414-421, 2019 | 18 | 2019 |
| Prioritization of high-cost new drugs for HCV: making sustainability ethical L Craxi, D Sacchini, P Refolo, R Minacori, V D'Aloiso, G Ricci, R Bruno, ... European review for medical and pharmacological sciences, 1044-1051, 2016 | 18 | 2016 |
| Development of a ready-to-use graphical tool based on artificial neural network classification: application for the prediction of late fecal incontinence after prostate cancer … M Carrara, E Massari, A Cicchetti, T Giandini, B Avuzzi, F Palorini, ... International Journal of Radiation Oncology* Biology* Physics 102 (5), 1533-1542, 2018 | 17 | 2018 |
| Evaluation of mediators associated with the inflammatory response in prostate cancer patients undergoing radiotherapy N Bedini, A Cicchetti, F Palorini, T Magnani, V Zuco, M Pennati, E Campi, ... Disease markers 2018, 2018 | 17 | 2018 |
| Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity NR Franco, MC Massi, F Ieva, A Manzoni, AM Paganoni, P Zunino, ... Radiotherapy and Oncology 159, 241-248, 2021 | 16 | 2021 |
| Local dose analysis to predict acute and late urinary toxicities after prostate cancer radiotherapy: Assessment of cohort and method effects E Mylona, A Cicchetti, T Rancati, F Palorini, C Fiorino, S Supiot, N Magne, ... Radiotherapy and Oncology 147, 40-49, 2020 | 16 | 2020 |
| External validation of a predictive model for acute skin radiation toxicity in the REQUITE breast cohort T Rattay, P Seibold, ME Aguado-Barrera, M Altabas, D Azria, GC Barnett, ... Frontiers in oncology 10, 575909, 2020 | 14 | 2020 |
| Predicting late fecal incontinence risk after radiation therapy for prostate cancer: new insights from external independent validation A Cicchetti, B Avuzzi, F Palorini, F Ballarini, C Stucchi, G Fellin, P Gabriele, ... International Journal of Radiation Oncology* Biology* Physics 102 (1), 127-136, 2018 | 13 | 2018 |
| SPOP deregulation improves the radiation response of prostate cancer models by impairing DNA damage repair R El Bezawy, M Tripari, S Percio, A Cicchetti, M Tortoreto, C Stucchi, ... Cancers 12 (6), 1462, 2020 | 12 | 2020 |
| Role of IMRT/VMAT-Based dose and volume parameters in predicting 5-year local control and survival in nasopharyngeal cancer patients NA Iacovelli, A Cicchetti, A Cavallo, S Alfieri, L Locati, E Ivaldi, ... Frontiers in Oncology 10, 518110, 2020 | 10 | 2020 |
| Texture analysis of T1‐w and T2‐w MR images allows a quantitative evaluation of radiation‐induced changes of internal obturator muscles after radiotherapy for prostate cancer E Scalco, T Rancati, I Pirovano, A Mastropietro, F Palorini, A Cicchetti, ... Medical Physics 45 (4), 1518-1528, 2018 | 9 | 2018 |
| Economic evaluation of Zepatier for the management of HCV in the Italian scenario FR Rolli, M Ruggeri, F Kheiraoui, C Drago, M Basile, C Favaretti, ... The European Journal of Health Economics 19, 1365-1374, 2018 | 8 | 2018 |
| Cost-effectiveness analysis of lesinurad/allopurinol versus febuxostat for the management of gout/hyperuricemia in Italy M Ruggeri, M Basile, C Drago, FR Rolli, A Cicchetti Pharmacoeconomics 36, 625-636, 2018 | 8 | 2018 |
